Is CytomX (CTMX) One of the Best Growth Stocks Under $30 to Buy Now?

CytomX (CTMX) and Relmada Therapeutics (RLMD) are identified as two of the best growth stocks currently trading under $30. These companies are highlighted for their potential investment value within the growth sector. Investors are analyzing these specific assets to determine if they represent the most strategic buying opportunities at their current price points. Both CTMX and RLMD are positioned as strong candidates for those seeking high-growth equities with a share price below thirty dollars.